Effects of single and concurrent intermittent administration of human PTH (1-34) and incadronate on cancellous and cortical bone of femoral neck in ovariectomized rats

Tohoku Journal of Experimental Medicine

Volumn 186, Issue 2, 1998, Pages 131-141

  Zhang, Liu ^a   Endo, Naoto ^a   Yamamoto, Noriaki ^a   Tanizawa, Tatsuhiko ^a   Takahashi, Hideaki E ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Bone histomorphometry; Concurrent treatment; Femoral neck; Incadronate; Parathyroid hormone

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; INCADRONIC ACID; PARATHYROID HORMONE[1-34];

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MASS; CANCELLOUS BONE; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFECT; DRUG SCREENING; FEMALE; FEMUR NECK; NONHUMAN; OSSIFICATION; OVARIECTOMY; RAT;

EID: 0032458825     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.186.131     Document Type: Article

References (21)

1. Bagi, C.M., Ammann, P., Rizzoli, R. & Miller, S.C. (1997) Effect of estrogen deficiency on cancellous and cortical bone structure and strength of the femoral neck in rats. Calcif. Tissue Int., 61, 336-344.
2. Cosman, F., Nieves, J., Woelfert, L., Shen, V. & Lindsay, R. (1998) Alendronate dose not block the anabolic effect of PTH in postmenopausal osteoporotic women. J. Bone Miner. Res., 13, 1051-1055.
3. Dempster, D.W., Cosman, F., Parisien, M., Shen, V. & Lindsay, R. (1993) Anabolic actions of PTH on bone. Endocr. Rev., 14, 690-709.
4. Frost, H.M. & Jee, W.S.S. (1992) On the rat model of human osteopenias and osteoporoses. Bone Miner., 18, 227-236.
5. Fujimoto, R., Nii, A., Okazaki, A., Miki, H. & Kawashima, H. (1990) Effect of disodium dihydrogen (cycloheptylamino) methylene bisphosphonate monohydrate (YM175) on the formation and resorption in rats and dogs. Histological examination. J. Bone Miner. Res., 5, Suppl. 2, 157.
6. Hock, J.M., Gera, I., Fonseca, J. & Raisz, L.G. (1988) Human parathyroid hormone-(1-34) increase bone mass in ovariectomized and orchidectomized rats. Endocrinology, 122, 1899-2904.
7. Kalu, D.N. (1991) The ovariectomized rat model of postmenopausal bone loss. Bone Miner., 15, 175-192.
8. Lauritzen, D.B., Balena, B., Shea, M., Seedor, J.G., Seedor, H.M., Marktos, H.M., Le, H.M., Toolan, B.C., Myers, S.R., Rodan, G.A. & Hayes, W.C. (1993) Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats. J. Bone Miner. Res., 8, 871-879.
9. Lindsay, R., Nieves, J., Formica, C., Henneman, E., Woelfert, L., Shen, V., Dempster, D.W. & Cosman, F. (1997) Randomised controlled study of effect of parathyroid hormone on vertebral bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet, 350, 550-555.
10. Liu, C.C. & Kalu, D.N. (1990) Human parathyroid hormone-(1-34) prevens bone loss and augments bone formation in sexually mature ovariectomized rats. /. Bone Miner. Res., 5, 973-982.
11. Motoie, H., Nakamura, T., Òuchi, N., Nishikawa, H., Kanoh, H., Abe, T. & Kawashima, H. (1995) Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction. J. Bone Miner. Res., 10, 910-920.
12. Nagao, Y., Ishitobi, Y., Fukushima, S., Kinoshita, H., Kawashima, H. & Kumagawa, M. (1990) YM175 inhibits osteoclast differentiation and bone resorbing action of mature osteoclasts. J. Bone Miner. Res., 5, Suppl. 2, 159.
13. Parfitt, A.M., Drezner, M.K., Glorieux, F.H., Kanis, J.A., Malluche, H., Meunier, P.J., Ott, S.M. & Recker, R.R. (1987) Bone histomorphometry: Standardization of nomenclature, symbols, and units. J. Bone Miner. Res., 2, 595-610.
14. Peng, Z., Tuukkanen, J. & Vaananen, H.K. (1994a) Exercise can provide protection against bone loss and prevent the decrease in mechanical strength of femoral neck in ovariectomized rats. J. Bone Miner. Res., 9, 1559-1564.
15. Peng, Z., Tuukkanen, J., Zhang, H., Jamsa, T. & Vaananen, H.K. (1994b) The mechanical strength of bone in different rat models of experimental osteoporosis. Bone, 15, 523-532.
16. Slovik, D.M., Rosenthal, D.I., Doppelt, S.H., Potts, J.T., Daly, M.A., Campbell, J.A. & Neer, R.M. (1986) Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1, 25-dihydroxyvitamin D. J. Bone Miner. Res., 1, 377-381.
17. Takahashi, H.E., Tanizawa, T., Hori, M. & Uzawa, T. (1991) Effect of intermittent administration of human parathyroid hormone (1-34) on experimental osteopenia of rats induced by ovariectomy. Cells and Materials, Suppl. 1, 113-117.
18. Wronski, T.J., Dann, L.M., Scott, K.S. & Crooke, L.R. (1989) Endocrine and phamacological suppressors of bone turnover protect against osteopenia in ovariectomized rats. Endocrinology, 125, 810-816.
19. Wronski, T.J. & Yen, C.F. (1991a) The ovariectomized rat as an model for postmenopausal bone loss. Cells and Materials, Suppl. 1, 69-74.
20. Wronski, T.J. & Yen, C.F. (1991b) Estrogen and diphosphonate treatment provide long-term protection against osteopenia in ovariectomized rats. J. Bone Miner. Res., 6, 387-394.
21. Yamamoto, N., Jee, W.S.S. & Ma, Y.F. (1995) Bone histomorphometric changes in the femoral neck of aging and ovariectomized rats. Anat. Rec., 243, 175-185.